NEW YORK (GenomeWeb News) – Abbott will be the sole distributor of Luminex Molecular Diagnostics’ respiratory viral panel outside of the United States, Luminex said today.
 
Under the agreement, Abbott will have exclusive rights to distribute the xTAG RVP outside of the US and semi-exclusive rights within the US, Luminex said.
 
The xTAG received 510(k) clearance from the US Food and Drug Administration in January 2008, and it was CE marked for sale in Europe in November 2006.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.